These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8593974)
1. Triflusal in the treatment of patients with chronic peripheral arteriopathy: multicentre double-blind clinical study vs placebo. Auteri A; Angaroni A; Borgatti E; Catalano M; De Vizzi GB; Forconi S; Fossati L; Girardello R; Ambrosoli L; Poli A Int J Clin Pharmacol Res; 1995; 15(2):57-63. PubMed ID: 8593974 [TBL] [Abstract][Full Text] [Related]
2. Compliance of geriatric patients subjected to antiplatelet agents with Triflusal in peripheral arteriopathy. Preliminary data. Zan S; Maselli M; Moniaci D; Varetto G; Ortensio M; Apostolou D; Comelli S; Scovazzi P Minerva Cardioangiol; 2002 Jun; 50(3):263-70. PubMed ID: 12107407 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the effect of low-dosage acetylsalicylic acid and triflusal in the prevention of cardiovascular events among young adults with ischemic cerebrovascular disease]. Matías-Guiu J; Alvarez-Sabín J; Codina A Rev Neurol; 1997 Nov; 25(147):1669-72. PubMed ID: 9484514 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial of iloprost in patients with intermittent claudication. Creager MA; Pande RL; Hiatt WR Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Gómez-Isla T; Blesa R; Boada M; Clarimón J; Del Ser T; Domenech G; Ferro JM; Gómez-Ansón B; Manubens JM; Martínez-Lage JM; Muñoz D; Peña-Casanova J; Torres F; Alzheimer Dis Assoc Disord; 2008; 22(1):21-9. PubMed ID: 18317243 [TBL] [Abstract][Full Text] [Related]
7. Action of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study. Messa GL; Franchi M; Auteri A; Di Perri T Int J Clin Pharmacol Res; 1993; 13(5):263-73. PubMed ID: 8200721 [TBL] [Abstract][Full Text] [Related]
8. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial. Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326 [TBL] [Abstract][Full Text] [Related]
9. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020 [TBL] [Abstract][Full Text] [Related]
10. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy. Marrapodi E; Leanza D; Giordano S; Nazzari M; Corsi C Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182 [TBL] [Abstract][Full Text] [Related]
11. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke. Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312 [TBL] [Abstract][Full Text] [Related]
12. Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery. Putz P; Buyse H; Delvaux D; Kutnowski M; Demulder A; Dumont N; Lavenne E; Claes R; Rosillon D Acta Chir Belg; 1991; 91(6):269-76. PubMed ID: 1781229 [TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial. Messa GL; Gelso E Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766 [TBL] [Abstract][Full Text] [Related]
14. [Clinico-biological effectiveness of triflusal during the postoperative period of patients with chronic ischemic syndrome of the extremities]. Arcas R; Herreros J; Rocha E; Honorato J; Aranza Perea J Rev Med Univ Navarra; 1981 Jun; 25(2):51-5. PubMed ID: 7339763 [TBL] [Abstract][Full Text] [Related]
15. [Triflusal in the prevention of vascular dementia]. López-Pousa S; Mercadal-Dalmau J; Martí-Cuadros AM; Vilalta-Franch J; Lozano-Gallego M Rev Neurol; 1997 Oct; 25(146):1525-8. PubMed ID: 9462972 [TBL] [Abstract][Full Text] [Related]
17. Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy. Bonfardeci G; Cimminiello C; Cantini L; Arpaia G; Aloisio M; Pozzi F Int Angiol; 1994 Dec; 13(4):339-42. PubMed ID: 7790757 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Mohler ER; Hiatt WR; Creager MA Circulation; 2003 Sep; 108(12):1481-6. PubMed ID: 12952839 [TBL] [Abstract][Full Text] [Related]
19. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Maksimović ZV Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398 [TBL] [Abstract][Full Text] [Related]